Vol. 61 No. 11 (2022): Acta Oncologica

Articles

• Socioeconomic inequality in cancer in the Nordic countries. A systematic review

  Gunn Ammitzbøll, Anne Katrine Graudal Levinsen, Trille Kristina Kjær, Freja Ejlebæk Ebbestad, Trine Allerslev Horsbøl, Lena Saltbæk, Sara Koed Badre-Esfahani, Andrea Joensen, Eva Kjeldsted, Maja Halgren Olsen, Susanne Oksbjerg Dalton

  1317-1331

  Published: 2022-11-02

  • PDF

• Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women

  Caroline Wium Hansen, Marianne Vogsen, Annette Raskov Kodahl

  1362-1368

  Published: 2022-11-02

  • PDF

• Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations

  Niels Herluf Paulsen, Camilla Qvortrup, Fie Juhl Vojdeman, Peter Plomgaard, Stig Ejdrup Andersen, Anne Ramlov, Birgitte Bertelsen, Maria Rossing, Claus Gyrup Nielsen, Elke Hoffmann-Lücke, Eva Greibe, Hanne Spangsberg Holm, Heidi Hvid Nielsen, Ihab Bishara Yousef Lolas, Jonna Skov Madsen, Marianne Lerbaek Bergmann, Morten Mørk, Palle B. Nielsen Fruekilde, Pernille Bøttger, Peter Clausager Petersen, Peter Henrik Nissen, Søren Feddersen, Troels K. Bergmann, Per Pfeiffer, Per Damkier

  1400-1405

  Published: 2022-11-02

  • PDF

• Factors associated with breast cancer mammography screening and breast self-examination in Irish women: results from the Irish Longitudinal Study on Ageing (TILDA)

  K. O’Sullivan, K. O’Sullivan

  1301-1308

  Published: 2022-11-02

• Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies

  Li Li, Li Li, Qin Huang, Jianhai Sun, Fei Yan, Wujie Wei, Zihui Li, Li Liu, Jie Deng

  1347-1353

  Published: 2022-11-02

  • PDF

• The current role of local treatment in metastatic prostate cancer: systematic review and meta-analysis

  Willy Baccaglini, Antonio F. Rodrigues, Saulo B. Teles, Nicolle M. Christofe, Felipe P. A. Glina, Gustavo C. Lemos, Rafael Sanchez-Salas, Rubén Olivares, Arie Carneiro

  1386-1393

  Published: 2022-11-02

  • PDF

• MR-based synthetic CT image for intensity-modulated proton treatment planning of nasopharyngeal carcinoma patients

  Shupeng Chen, Yinglin Peng, An Qin, Yimei Liu, Chong Zhao, Xiaowu Deng, Rohan Deraniyagala, Craig Stevens, Xuanfeng Ding

  1417-1424

  Published: 2022-11-02

  • PDF

• Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study

  Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, Carmen Botella-Garcia, Micha Srour, Steven Le Gouill, Gaelle Guillerm, Rémy Gressin, Stéphanie Nguyen Quoc, Sabine Furst, Adrien Chauchet, David Sibon, Philippe Lewalle, Xavier Poiré, Natacha Maillard, Alban Villate, Michael Loschi, Jérôme Paillassa, Yves Beguin, Rémy Dulery, Jean-Jacques Tudesq, Amandine Fayard, Marie C. Béné, Vincent Camus, Patrice Chevallier, Amandine Le Bourgeois

  1332-1338

  Published: 2022-11-02

  • PDF

• Societal costs of ovarian cancer in a population-based cohort – a cost of illness analysis

  Charlotte Palmqvist, Josefine Persson, Per Albertsson, Pernilla Dahm-Kähler, Mia Johansson

  1369-1376

  Published: 2022-11-02

  • PDF

• Coverage probability planning for simultaneously integrated boosts of inguinal lymph nodes in vulvar cancer

  Sandy Mohamed, Marianne S. Assenholt, Lars Fokdal, Jesper Kallehauge, Jacob Chr. Lindegaard, Kari Tanderup

  1406-1411

  Published: 2022-11-02

  • PDF

• Sexually transmitted diseases in cancer patients diagnosed under the age of 20 years – a national registry-based cohort study from Finland

  Liisa Korhonen, Laura Madanat-Harjuoja, Elli Hirvonen, Janne Pitkäniemi, Nea Malila, Mervi Taskinen

  1309-1316

  Published: 2022-11-02

  • PDF

• Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study

  Rosa Lauppe, Fredrik O. L. Nilsson, Hanna Fues Wahl, Mathias Lilja, Anders Vikström, Sandra T. Asanin

  1354-1361

  Published: 2022-11-02

  • PDF

• Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study

  Raffaele Longo, Victoire Thiebaut, Pierre-Olivier Legros, Marco Campitiello, Francesca Plastino, Christophe Goetz, Bogdan Margineanu, Julie Pujois, Michel Gunther, Julie Egea, Chloé Wendel

  1394-1399

  Published: 2022-11-02

  • PDF

• Single-molecule array assay reveals the prognostic impact of plasma LRIG1 in ovarian carcinoma

  Alexandra Lorenzzi Löfgren de Melo, Anna Linder, Karin Sundfeldt, David Lindquist, Håkan Hedman

  1425-1433

  Published: 2022-11-02

  • PDF

• Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study

  Soraya Benguerfi, Roch Houot, Thierry Lesimple, Roch Houot, Charles Ricordel, Régine Lamy, Delphine Deniel Lagadec, Romain Corre

  Published: 2023-10-16

  • PDF

• Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study

  Yashar Khoshkar, Hari T. Vigneswaran, Sandra Eloranta, Therese M.-L. Andersson, Frida Schain, Anton Boman, Martin Dahlkild, Johan Liwing, Amy Leval, Olof Akre, Markus Aly

  1377-1385

  Published: 2022-11-02

  • PDF

• Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma

  Ceyda Baskan, Ebru Atasever Akkas, Sabite Emine Gökce, Sibel Ozdogan

  1412-1416

  Published: 2022-11-02

  • PDF